Clinical Trial Supply and Logistics Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032

CHAPTER 1. Industry Overview of Clinical Trial Supply and Logistics Market

1.1. Definition and Scope

1.1.1. Definition of Clinical Trial Supply & Logistics

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Clinical Trial Supply and Logistics Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Clinical Trial Supply and Logistics Market By Service

1.2.3. Clinical Trial Supply and Logistics Market By Phase

1.2.4. Clinical Trial Supply and Logistics Market By Therapeutic Area

1.2.5. Clinical Trial Supply and Logistics Market By End-user

1.2.6. Clinical Trial Supply and Logistics Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Source

2.2.2. Primary Source

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Clinical Trial Supply and Logistics Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Clinical Trial Supply and Logistics Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Price Trend of Key Raw Material

3.8.1. Raw Material Suppliers

3.8.2. Proportion of Manufacturing Cost Structure

3.8.2.1. Raw Material

3.8.2.2. Labor Cost

3.8.2.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2022

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022

4.2. R&D Status of Major Manufacturers in 2022

CHAPTER 5. Clinical Trial Supply and Logistics Market By Service

5.1. Introduction

5.2. Clinical Trial Supply and Logistics Revenue By Service

5.2.1. Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast, By Service, 2020-2032

5.2.2. Logistics and Distribution

5.2.2.1. Logistics and Distribution Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3. Packaging, Labeling, and Blinding

5.2.3.1. Packaging, Labeling, and Blinding Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.4. Storage & Retention

5.2.4.1. Storage & Retention Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.5. Comparator Sourcing

5.2.5.1. Comparator Sourcing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.6. Manufacturing

5.2.6.1. Manufacturing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.7. Others

5.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 6. Clinical Trial Supply and Logistics Market By Phase

6.1. Introduction

6.2. Clinical Trial Supply and Logistics Revenue By Phase

6.2.1. Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast, By Phase, 2020-2032

6.2.2. Phase I

6.2.2.1. Phase I Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3. Phase II

6.2.3.1. Phase II Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.4. Phase III

6.2.4.1. Phase III Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.5. Phase IV

6.2.5.1. Phase IV Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 7. Clinical Trial Supply and Logistics Market By Therapeutic Area

7.1. Introduction

7.2. Clinical Trial Supply and Logistics Revenue By Therapeutic Area

7.2.1. Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast, By Therapeutic Area, 2020-2032

7.2.2. Oncology

7.2.2.1. Oncology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.3. CNS and Mental Disorders

7.2.3.1. CNS and Mental Disorders Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.4. Respiratory Diseases

7.2.4.1. Respiratory Diseases Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.5. Cardiovascular Diseases

7.2.5.1. Cardiovascular Diseases Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.6. Others

7.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 8. Clinical Trial Supply and Logistics Market By End-user

8.1. Introduction

8.2. Clinical Trial Supply and Logistics Revenue By End-user

8.2.1. Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast, By End-user, 2020-2032

8.2.2. Pharmaceuticals

8.2.2.1. Pharmaceuticals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.3. Medical Device

8.2.3.1. Medical Device Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.4. Biologicals

8.2.4.1. Biologicals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 9. North America Clinical Trial Supply and Logistics Market By Country 

9.1. North America Clinical Trial Supply and Logistics Market Overview

9.2. U.S.

9.2.1. U.S. Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Service, 2020-2032

9.2.2. U.S. Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Phase, 2020-2032

9.2.3. U.S. Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032

9.2.4. U.S. Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By End-user, 2020-2032

9.3. Canada

9.3.1. Canada Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Service, 2020-2032

9.3.2. Canada Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Phase, 2020-2032

9.3.3. Canada Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032

9.3.4. Canada Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By End-user, 2020-2032

9.4. North America PEST Analysis

CHAPTER 10. Europe Clinical Trial Supply and Logistics Market By Country

10.1. Europe Clinical Trial Supply and Logistics Market Overview

10.2. U.K.

10.2.1. U.K. Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Service, 2020-2032

10.2.2. U.K. Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Phase, 2020-2032

10.2.3. U.K. Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032

10.2.4. U.K. Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By End-user, 2020-2032

10.3. Germany

10.3.1. Germany Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Service, 2020-2032

10.3.2. Germany Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Phase, 2020-2032

10.3.3. Germany Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032

10.3.4. Germany Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By End-user, 2020-2032

10.4. France

10.4.1. France Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Service, 2020-2032

10.4.2. France Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Phase, 2020-2032

10.4.3. France Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032

10.4.4. France Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By End-user, 2020-2032

10.5. Spain

10.5.1. Spain Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Service, 2020-2032

10.5.2. Spain Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Phase, 2020-2032

10.5.3. Spain Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032

10.5.4. Spain Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By End-user, 2020-2032

10.6. Rest of Europe

10.6.1. Rest of Europe Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Service, 2020-2032

10.6.2. Rest of Europe Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Phase, 2020-2032

10.6.3. Rest of Europe Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032

10.6.4. Rest of Europe Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By End-user, 2020-2032

10.7. Europe PEST Analysis

CHAPTER 11. Asia Pacific Clinical Trial Supply and Logistics Market By Country

11.1. Asia Pacific Clinical Trial Supply and Logistics Market Overview

11.2. China

11.2.1. China Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Service, 2020-2032

11.2.2. China Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Phase, 2020-2032

11.2.3. China Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032

11.2.4. China Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By End-user, 2020-2032

11.3. Japan

11.3.1. Japan Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Service, 2020-2032

11.3.2. Japan Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Phase, 2020-2032

11.3.3. Japan Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032

11.3.4. Japan Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By End-user, 2020-2032

11.4. India

11.4.1. India Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Service, 2020-2032

11.4.2. India Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Phase, 2020-2032

11.4.3. India Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032

11.4.4. India Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By End-user, 2020-2032

11.5. Australia

11.5.1. Australia Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Service, 2020-2032

11.5.2. Australia Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Phase, 2020-2032

11.5.3. Australia Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032

11.5.4. Australia Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By End-user, 2020-2032

11.6. South Korea

11.6.1. South Korea Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Service, 2020-2032

11.6.2. South Korea Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Phase, 2020-2032

11.6.3. South Korea Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032

11.6.4. South Korea Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By End-user, 2020-2032

11.7. Rest of Asia-Pacific

11.7.1. Rest of Asia-Pacific Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Service, 2020-2032

11.7.2. Rest of Asia-Pacific Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Phase, 2020-2032

11.7.3. Rest of Asia-Pacific Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032

11.7.4. Rest of Asia-Pacific Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By End-user, 2020-2032

11.8. Asia Pacific PEST Analysis

CHAPTER 12. Latin America Clinical Trial Supply and Logistics Market By Country

12.1. Latin America Clinical Trial Supply and Logistics Market Overview

12.2. Brazil

12.2.1. Brazil Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Service, 2020-2032

12.2.2. Brazil Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Phase, 2020-2032

12.2.3. Brazil Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032

12.2.4. Brazil Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By End-user, 2020-2032

12.3. Mexico

12.3.1. Mexico Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Service, 2020-2032

12.3.2. Mexico Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Phase, 2020-2032

12.3.3. Mexico Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032

12.3.4. Mexico Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By End-user, 2020-2032

12.4. Rest of Latin America

12.4.1. Rest of Latin America Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Service, 2020-2032

12.4.2. Rest of Latin America Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Phase, 2020-2032

12.4.3. Rest of Latin America Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032

12.4.4. Rest of Latin America Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By End-user, 2020-2032

12.5. Latin America PEST Analysis

CHAPTER 13. Middle East & Africa Clinical Trial Supply and Logistics Market By Country 

13.1. Middle East & Africa Clinical Trial Supply and Logistics Market Overview

13.2. GCC

13.2.1. GCC Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Service, 2020-2032

13.2.2. GCC Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Phase, 2020-2032

13.2.3. GCC Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032

13.2.4. GCC Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By End-user, 2020-2032

13.3. South Africa

13.3.1. South Africa Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Service, 2020-2032

13.3.2. South Africa Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Phase, 2020-2032

13.3.3. South Africa Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032

13.3.4. South Africa Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By End-user, 2020-2032

13.4. Rest of Middle East and Africa

13.4.1. Rest of Middle East & Africa Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Service, 2020-2032

13.4.2. Rest of Middle East & Africa Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Phase, 2020-2032

13.4.3. Rest of Middle East & Africa Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032

13.4.4. Rest of Middle East & Africa Clinical Trial Supply and Logistics Revenue (USD Billion) and Forecast By End-user, 2020-2032

13.5. Middle East & Africa PEST Analysis

CHAPTER 14. Player Analysis Of Clinical Trial Supply & Logistics Market

14.1. Clinical Trial Supply & Logistics Market Company Share Analysis

14.2. Competition Matrix

14.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment

14.2.2. New Product Launches and Product Enhancements

14.2.3. Mergers And Acquisition In Global Clinical Trial Supply and Logistics Market

14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 15. Company Profile

15.1. Parexel

15.1.1. Company Snapshot

15.1.2. Business Overview

15.1.3. Financial Overview

15.1.3.1. Revenue (USD Billion), 2022

15.1.3.2. Parexel 2022 Clinical Trial Supply and Logistics Business Regional Distribution

15.1.4. Product/Service and Specification

15.1.5. Recent Developments & Business Strategy

15.2. Almac Group

15.3. Marken

15.4. DHL

15.5. Catalent, Inc.

15.6. Movianto

15.7. FedEx

15.8. Piramal Pharma Solutions

15.9. UDG Healthcare

15.10. Packaging Coordinators Inc.

15.11. Thermo Fisher Scientific.